Literature DB >> 12616147

Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis.

Stuart S Olmsted1, Leslie A Meyn, Lisa C Rohan, Sharon L Hillier.   

Abstract

BACKGROUND: It is known that glycosidases and proteases are produced by the anaerobic gram-negative bacteria associated with bacterial vaginosis (BV). We hypothesized that these enzymes enzymatically degrade mucins, thereby destroying the mucus gel that otherwise helps protect against sexually transmitted pathogens, including HIV. GOAL: The goal was to determine glycosidase and protease production by vaginal bacteria associated with BV and to compare these with symptoms and signs of abnormal discharge and to test vaginal fluid viscosity. STUDY
DESIGN: The anaerobic gram-negative rods recovered from the vaginas of 153 women with normal flora, intermediate flora, or BV were tested for production of sialidase, fucosidase, galactosidase, glucosaminidase, and glycine and arginine aminopeptidases.
RESULTS: Women with BV had higher frequencies and concentrations of bacteria producing mucin-degrading enzymes than did women with intermediate and normal flora (P < 0.001). Women with higher concentrations of bacteria producing mucin-degrading enzymes were more likely to have a thin discharge associated with BV (P < 0.001). The viscosity of diluted vaginal fluid samples from women with BV was significantly lower than those from women with normal flora (P = 0.001).
CONCLUSION: These data support the hypothesis that BV organisms degrade the protective mucus gel.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616147     DOI: 10.1097/00007435-200303000-00016

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  45 in total

1.  Severity of bacterial vaginosis and the risk of sexually transmitted infection.

Authors:  Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2011-02-27       Impact factor: 8.661

2.  Cervicitis of unknown etiology.

Authors:  Stephanie N Taylor
Journal:  Curr Infect Dis Rep       Date:  2014-07       Impact factor: 3.725

3.  Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.

Authors:  Samuel K Lai; Ying-Ying Wang; Kaoru Hida; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

4.  Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.

Authors:  J Paul Brooks; David J Edwards; Diana L Blithe; Jennifer M Fettweis; Myrna G Serrano; Nihar U Sheth; Jerome F Strauss; Gregory A Buck; Kimberly K Jefferson
Journal:  Contraception       Date:  2016-11-29       Impact factor: 3.375

Review 5.  The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV.

Authors:  Mara Farcasanu; Douglas S Kwon
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

6.  Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis.

Authors:  C S Bradshaw; A N Morton; S M Garland; L B Horvath; I Kuzevska; C K Fairley
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy.

Authors:  Caroline Mitchell; Jennifer Balkus; Kathy Agnew; Richard Lawler; Jane Hitti
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

8.  Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection.

Authors:  David H Martin; Marcela Zozaya; Rebecca A Lillis; Leann Myers; M Jacques Nsuami; Michael J Ferris
Journal:  J Infect Dis       Date:  2013-03-12       Impact factor: 5.226

9.  Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis.

Authors:  Warren G Lewis; Lloyd S Robinson; Nicole M Gilbert; Justin C Perry; Amanda L Lewis
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

10.  Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.

Authors:  Samuel K Lai; Kaoru Hida; Shetha Shukair; Ying-Ying Wang; Anna Figueiredo; Richard Cone; Thomas J Hope; Justin Hanes
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.